Ledger.Open graph →
SEC Form D · filed August 21, 2009

Gloucester Pharmaceuticals Inc

Offering
$28.9M
Sold
$20.3M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (18)

Martin Vogelbaum · Cambridge, MADirectorNicholas Vrolijk · Cambridge, MAExecAlan B. Colowick · Cambridge, MAExec · DirectorDonald J. Hayden · Cambridge, MAExec · DirectorJean C. Nichols · Cambridge, MAExecSeth Harrison · Cambridge, MADirectorJay Moorin · Cambridge, MADirectorDavid Schnell · Cambridge, MADirectorThomas Dyrberg · Cambridge, MADirectorDavid Hanna · Sunnyvale, CAExecCurtis Feeny · Sunnyvale, CAExec · DirectorWilliam Gurley · Sunnyvale, CAExecMason L. Kuehl · Denton, TXDirectorChris Miller · San Mateo, CADirectorJack H. Brier · Topeka, KSDirectorAndreas P. Graham · Corona Del Mar, CADirectorMark L. Ricciardelli · Corona Del Mar, CAExec · DirectorThomas Dyrberg · Bernardsville, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗